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		Antimicrobial	Resistance	
“we	will	cut	inappropriate	
prescribing	in	the	UK	by	half	by	
2020…”	Dave	
2016/17	CQUIN	–	AMR	
	
• By	Q4	90%	antibiotic	prescriptions	reviewed	within	72	hours		
• Reduction	of	total,	piperacillin/tazobactam	and	carbapenem	
antibiotic	usage	by	1%	
2017/19	CQUIN	–	Reducing	the	impact	of	serious	infections:	
	
• Antibiotic	usage	reduced	by	at	least	1-2%	
		CQUINs	 To	be	presented	on	1st	Dec	@	FIS		Evaluation	of	2016/17	CQUIN	AMR:	
Only	43.2%	of	trusts	achieved	
reduction	of	1%	for	total	Abx	use	
ARK-Hospital 
(Antibiotic Review Kit – Hospital)  
A	5-year	applied	research	programme	funded	by	NIHR	
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The	overarching	aim	of	ARK	is	to	reduce	the	incidence	of	serious	
infections	caused	by	antibiotic-resistant	bacteria	in	the	future,	
through	substantially	and	safely	reducing	antibiotic	use	in	
hospitals	now		
•  Complex	behaviour	change	approaches	
•  Based	on	similar	successful	approaches	in	primary	care	
•  Aimed	at	whether	to	stop	antibiotics	or	not	at	review	and	revise	
	
		What	is	ARK-Hospital?	
Main	trial	
		ARK-Hospital	timeline	
Spring	2016	
Pre-trial	work	
	
	
	
	
Autumn	2017		
3	pilot	sites	
Winter	2017-19		
33	further	sites	
Spring	2017		
Feasibility	study	
1.  Information	for	prescribers	about	Review	&	Revise	decision	making	
	
2.  A	decision	aid	applied	to	antibiotic	prescriptions	
3.  Information	for	nurses	and	pharmacists	
4.  Information	for	patients	
	
5.  A	structure	for	team	meetings	
		ARK-Hospital	provides:	
1.   Information	for	prescribers	about	Review	&	Revise	decision	making	
	
2.  A	decision	aid	applied	to	antibiotic	prescriptions	
3.  Information	for	nurses	and	pharmacists	
4.  Information	for	patients	
	
5.  A	structure	for	team	meetings	
Online	learning	tool	
-  Website/App	
-  Info	about	R&R	
-  Evidence	of	harms	of	Abxs	
-  Endorsed	by	specialist	
societies	
		ARK-Hospital	provides:	122	clinicians	
completed	the	tool!	
1.  Information	for	prescribers	about	Review	&	Revise	decision	making	
	
2.   A	decision	aid	applied	to	antibiotic	prescriptions	
3.  Information	for	nurses	and	pharmacists	
4.  Information	for	patients	
	
5.  A	structure	for	team	meetings	
Modified	antibiotic	prescriptions	
-  Acknowledges	uncertainty	
-  Helps	person	reviewing	Abx	
-  Prompts	72hr	review	
		ARK-Hospital	provides:	
1.  Information	for	prescribers	about	Review	&	Revise	decision	making	
	
2.  A	decision	aid	applied	to	antibiotic	prescriptions	
3.   Information	for	nurses	and	pharmacists	
4.  Information	for	patients	
	
5.  A	structure	for	team	meetings	
Face-to	face	education	+	online	tool	
-  Confirm	use	of	decision	aid	
-  Alert	doctors	to	review	Abx	
		ARK-Hospital	provides:	
1.  Information	for	prescribers	about	Review	and	Revise	decision	making	
	
2.  A	decision	aid	applied	to	antibiotic	prescriptions	
3.  Information	for	nurses	and	pharmacists	
4.   Information	for	patients	
	
5.  A	structure	for	team	meetings	
		ARK-Hospital	provides:	
A	patient	leaflet	
		4.	Information	for	patients	
1.  Information	for	prescribers	about	Review	and	Revise	decision	making	
	
2.  A	decision	aid	applied	to	antibiotic	prescriptions	
3.  Information	for	nurses	and	pharmacists	
4.  Information	for	patients	
	
5.   A	structure	for	team	meetings,	monitoring	and	feedback	
Kick-off	meetings	
Monitoring	of	Abx	prescriptions	
Feedback	to	clinical	teams	
		ARK-Hospital	provides:	
Total	of	30	cross-sectional	
audits	and	20	feedback	sessions	
Feasibility study quantitative data 
•  3	months	from	April	to	July	2017	
•  588	antibiotic	prescriptions	
• Point	prevalence	surveys	
•  Weeks	1,	2,	3,	4,	6,	8	and	12	
	
• Medical	specialties:	
•  Acute	medicine,	respiratory,	elderly	care,	endocrine,	gastroenterology	
		Quantitative	data	
		Prescriptions	r/vd	within	72	Hours	
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CQUIN	Target	
		Prescriptions	using	decision	aid	
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ARK	Target	
		Prescriptions	stopped	within	72hr	r/v	
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Trust	Baseline	
Feasibility study qualitative data 
		Patient	interviews	
Review	and	revise	
“I	thought	it	was	very	informative,	concise	and	
straightforward	and	in	nice,	easy	terms,	that	most	
people	could	understand.	It	looks	nice	and	neat	and	
easy	to	read.”		Brighton,	Patient	6	
Leaflet	
“I	agree	with	how	it’s	done…continue	or	discontinue,	
you’ve	got	to	wait	for	the	results	and	I	think	that’s	what	
happened	with	me.	They	got	the	results	in	and	then	it	was	
discontinued	and	that’s	fine,	I’m	happy	with	that.”	
Brighton,	Patient	1	
		Core	Team	Focus	Group	&	Champion	Interview	
“It	has	been	enormously	rewarding	to	do	
ARK…It	has	felt	like	a	very	good	use	of	my	
time,	in	terms	of	making	positive	impact	
on	patients	in	the	hospital...The	idea	of	
capturing	diagnostic	uncertainty	at	the	
time	you	write	an	antibiotic	prescription	
appears	to	have	tremendous	resonance	
to	people.”			
	
Brighton,	ARK	Champion	
Feedback	
• Piloting	and	planning	ahead	
• Resources	developed	
• Effective	feedback	of	data	
Challenges	
• Sustainability	
		Wider	clinical	team	focus	groups	
“I	think	everybody	in	AMU	found	it	[the	
feedback]	quite	helpful…I	suppose	
getting,	seeing	the	data	can	then	change	
what	we’re	doing…	there	was	one	week	
and	I	think	that	we	did	very	well,	in	terms	
of	stopping	the	antibiotics,	so	then	
everybody	the	next	week	was	stopping	
all	the	antibiotics.”		
	
Brighton,	Junior	Doctor	
Feedback	
• Benefits	of	the	Decision	Aid	
• Support	from	the	core	team	
• Challenges	
•  Involvement	of	different	
professional	groups	
• Use	of	the	ARK	website	and	
ARK	patient	leaflet	
 
 
 
Interested? 
Visit: http://www.arkstudy.ox.ac.uk/ 
 
Or contact: Professor Martin Llewelyn 
M.J.Llewelyn@bsms.ac.uk 
 
